FDA Releases Draft Guidance on Analgesic Indications for Prescription Pain Management

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document that provides recommendations to pharmaceutical companies on developing prescription drugs for managing acute, chronic, and breakthrough pain, as well as labeling considerations for these medications.